On January 24, Prof. Yao Meicun, deputy director of Qingyuan High-tech Zone Management Committee and doctoral supervisor of Sun Yat-sen University School of Pharmacy (Shenzhen), visited feellife and gave a discussion on 'in-depth study of evidence-based medicine and its clinical application of aerosolized drug use'. Negotiate with our company for scientific research projects.

During the visit, Professor Yao Meicun made a detailed inquiry and understanding of the experimental area and experimental equipment of the Feellife R&D Center, and discussed the application status of nebulization therapy at home and abroad and the application of nebulization liquid with Edward, chairman of the group, and core R&D personnel. Match the future trends of nebulizers.

Professor Yao Meicun said that with the development of medical technology, the treatment of respiratory diseases has been continuously standardized, and atomization inhalation has become the mainstream treatment method. However, the types and dosage forms of aerosolized drugs are far from keeping up with people's disease needs. Therefore, this scientific research needs to be done in 'small' and 'big', based on the 'small' incision of 'nebulization', and do a good job in the 'big' cause of 'aerosolization and evidence-based medicine'.

Chairman Edward fully affirmed the guidance of Professor Yao Meicun, and expressed his expectation that under the leadership of Professor Yao Meicun, close cooperation with medical colleges and universities will be established to further explore and explore the application of nebulizer + nebulizer in medical and health care. The application prospect and research and development significance of the field will make a positive contribution to providing a third way of drug delivery for human beings!